Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. (S)(S) 200.80(b)(4), 200.83 and 240.24b-2 COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT Collaborative Development and Marketing Agreement TABLE OF CONTENTS...Collaborative Development and Marketing Agreement • November 12th, 2002 • Dendreon Corp • Pharmaceutical preparations • New York
COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENTCollaborative Development and Marketing Agreement • September 13th, 2004 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT is entered into as of August 12, 2004 (the “Effective Date”), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation having an address of Cedar Brook Corporate Center, 4C Cedar Brook Drive, Cranbury, New Jersey 08512 (“Palatin”) and KING PHARMACEUTICALS, INC., a Tennessee corporation having an address of 501 Fifth Avenue, Bristol, Tennessee 37620, (“King”). Each of King and Palatin is sometimes referred to individually herein as a “Party” and collectively as the “Parties”.
EXHIBIT 10.28 COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENTCollaborative Development and Marketing Agreement • January 10th, 2002 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York
SECOND AMENDMENT AND AGREEMENTCollaborative Development and Marketing Agreement • December 23rd, 2005 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This SECOND AMENDMENT AND AGREEMENT (this “Agreement”) is entered into as of December 16, 2005 (the “Effective Date”), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation having an address of Cedar Brook Corporate Center, 4C Cedar Brook Drive, Cranbury, New Jersey 08512 (“Palatin”) and KING PHARMACEUTICALS, INC., a Tennessee corporation having an address of 501 Fifth Avenue, Bristol, Tennessee 37620 (“King”). Each of King and Palatin is sometimes referred to individually herein as a “Party” and collectively as the “Parties”. Any capitalized terms undefined herein shall have the meaning ascribed to them in the CDM Agreement.
EXHIBIT 10.2 COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT This COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT is entered into as of August 12, 2004 (the "Effective Date"), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation...Collaborative Development and Marketing Agreement • March 21st, 2005 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
